Efficacy of anti-interleukin-1 treatment in colchicine-resistant arthritis in patients with familial Mediterranean fever

Kehribar D. Y., Özgen M.

EUROPEAN JOURNAL OF RHEUMATOLOGY, vol.8, no.1, pp.16-19, 2021 (ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 8 Issue: 1
  • Publication Date: 2021
  • Doi Number: 10.5152/eurjrheum.2020.20126
  • Journal Name: EUROPEAN JOURNAL OF RHEUMATOLOGY
  • Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Page Numbers: pp.16-19
  • Keywords: Anti-interleukin-1 antagonist protein, arthritis, familial Mediterranean fever, MUTATIONS, GENE
  • Ondokuz Mayıs University Affiliated: Yes

Abstract

Objective: In the familial Mediterranean fever (FMF) clinic, arthritis is among the most common symptoms, and it generally responds well to colchicine treatment. However; cases of patients with chronic prolonged colchicine-resistant arthritis have been reported, and there are inadequate studies on the treatments to be used for such patients.